PLK1 and cancer: The authors reported that MSNPs inhibit cancer cell invasion via ROS- and NOX4-dependent mechanisms, reduce by 80% the level of PLK1 mRNA in metastatic breast cancer cells of mouse lungs, and increase the overall survival of treated animals.